Yuto Hamada,Peter G Gibson
Yuto Hamada
Iris M Otani,Allison Ramsey
Iris M Otani
Insights into Clinical Challenges and Management of Primary and Secondary Antibody Deficiency in Pregnancy [0.03%]
原发性和继发性妊娠期免疫缺陷的临床挑战及管理见解
Ahmed Elmoursi,Caroline Charlier,Charlotte Cunningham-Rundles et al.
Ahmed Elmoursi et al.
Pregnancy in patients with primary or secondary antibody deficiencies presents unique clinical challenges shaped by impaired humoral immunity, increased susceptibility to infection, and decreased maternal-fetal placental IgG transfer. Immun...
Luciana Kase Tanno,Anne K Ellis,Lubnaa Hossenbaccus et al.
Luciana Kase Tanno et al.
Anaphylaxis during pregnancy is a rare but potentially life-threatening condition for both mother and fetus, requiring rapid recognition and immediate treatment. Although the fundamental mechanisms of anaphylaxis in pregnancy are similar to...
Allergy and Asthma Medication Use in Pregnancy: Safety and Clinical Considerations [0.03%]
孕期过敏和哮喘药物使用的安全性及临床考虑因素
Jennifer Namazy,Isabella Novoa-Caicedo,Sergio E Chiarella et al.
Jennifer Namazy et al.
Asthma and allergic diseases are highly prevalent among pregnant women, and inadequate control is associated with increased risks of adverse maternal and fetal outcomes. Importantly, concerns about drug safety often result in therapeutic he...
Second-generation H1-antihistamines do not alter dementia risk in type 2 inflammatory diseases: A target trial emulation using real-world data [0.03%]
二代H1抗组胺药不会改变2型炎症性疾病患者的痴呆风险：利用真实世界数据进行目标试验模拟研究
Henning Olbrich,Pavel Kolkhir,Torsten Zuberbier et al.
Henning Olbrich et al.
Background: Type 2 chronic inflammatory diseases such as chronic urticaria (CU), chronic sinusitis (CS), and allergic rhinitis (AR) are commonly treated with second-generation H1-antihistamines (sgAH). Although considered...
Pilot of a remote digital therapeutic exercise program in obesity and asthma [0.03%]
肥胖和哮喘远程数字治疗运动项目试点试验
Mariel T Sullivan,Katherine Huether Callander,Derek Devine et al.
Mariel T Sullivan et al.
Background: Individuals with obesity and asthma experience poor asthma-related quality of life and asthma control, and high rates of asthma-related hospitalizations. ...
Nuts and Bolts of Relationship Centered Communication in the Allergy Immunology Clinic [0.03%]
过敏免疫门诊中以患者为中心的沟通技巧
Brian C Schroer,Jaclyn Bjelac,Natalie Chapman et al.
Brian C Schroer et al.
Effective clinical communication is foundational to healthcare delivery. Models of clinician-centered communication have evolved to patient-centered paradigms. This review highlights approaches that can further advance collaborative care by...
Safety of remibrutinib in chronic spontaneous urticaria: a pooled analysis of REMIX-1 and REMIX-2 trials [0.03%]
remibrutinib在慢性自发性荨麻疹患者中的安全性：REMIX-1和REMIX-2研究的汇总分析
Ana Maria Giménez-Arnau,Artem Zharkov,Bin Yang et al.
Ana Maria Giménez-Arnau et al.
Background: Remibrutinib, an oral, highly selective Bruton's tyrosine kinase inhibitor (BTKi), showed sustained efficacy in phase 3 REMIX trials in chronic spontaneous urticaria. ...
IMPACT (Immune Monitoring and Phenotype Assessment of Clinical Trajectory) for Patients with Inborn Errors of Immunity from the Primary Immune Deficiency Treatment Consortium (PIDTC) [0.03%]
原发性免疫缺陷治疗协会(PIDTC)的先天性免疫缺陷患者的IMPACT(临床病程的免疫监测和表型评估)研究
Danielle E Arnold,Hesham Eissa,Elizabeth Dunn et al.
Danielle E Arnold et al.
Background: Evaluating natural history and outcomes of rare inborn errors of immunity (IEIs) has been challenging due to the diverse disease manifestations and lack of standardized data. ...